miRNAs in Normal and Malignant Hematopoiesis. 2017

Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
Department of Hematology and Oncology, Tokai University School of Medicine, Hiratsuka 259-1193, Japan. kotaki-r@k-lab.jp.

Lineage specification is primarily regulated at the transcriptional level and lineage-specific transcription factors determine cell fates. MicroRNAs (miRNAs) are 18-24 nucleotide-long non-coding RNAs that post-transcriptionally decrease the translation of target mRNAs and are essential for many cellular functions. miRNAs also regulate lineage specification during hematopoiesis. This review highlights the roles of miRNAs in B-cell development and malignancies, and discusses how miRNA expression profiles correlate with disease prognoses and phenotypes. We also discuss the potential for miRNAs as therapeutic targets and diagnostic tools for B-cell malignancies.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
October 2007, Oncogene,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
January 2007, Annals of oncology : official journal of the European Society for Medical Oncology,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
January 2013, Epigenomics,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
July 2008, Current opinion in hematology,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
February 2005, Seminars in cell & developmental biology,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
September 2020, International journal of molecular sciences,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
August 2017, Cold Spring Harbor perspectives in medicine,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
January 2014, Leukemia,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
September 2012, Leukemia,
Ryutaro Kotaki, and Ryo Koyama-Nasu, and Natsuko Yamakawa, and Ai Kotani
January 2015, Epigenomics,
Copied contents to your clipboard!